Minerva Neurosciences, Inc.
NERV· Nasdaq
Released Mar 11, 2026, before the open
10-K filed Mar 11, 2026, 70 days after period end · 0001193125-26-101117
derived · Computed from the longer spans the company filed.
| Metric | Q4 2025dderived from reported figures | Q4 2024dderived from reported figures | Q4 2023dderived from reported figures | Q4 2022dderived from reported figures |
|---|---|---|---|---|
| Net Income | -$283.67M | -$4.27M | -$9.02M | -$6.73M |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Minerva Neurosciences, Inc. · CIK 1598646 · Engraved from SEC EDGAR
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
ended Dec 31, 2025 · filed Mar 11, 2026 · 70 d after period end
8.1% from the close of Mar 10, 2026 to the close of Mar 11, 2026, the first after the release.